ArticleHepatology international2021
The global trends and regional differences in incidence and mortality of hepatitis A from 1990 to 2019 and implications for its prevention.
Article in Hepatology international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
60 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Immunogenicity and safety of inactivated TZ84- vs. HM175-based hepatitis A vaccines in pediatric populations: A systematic review and meta-analysis.Human vaccines & immunotherapeutics · 2026Pooled it
- Determining the burden of foodborne hepatitis A spread by food handlers: suggestions for a targeted vaccination?Frontiers in public health · 2025Pooled it
- Evolution and Impact of Hepatitis A Epidemiology in Europe-Systematic Literature Review of the Last 20 Years.Journal of viral hepatitis · 2025Pooled it
- Occurrence of Hepatitis A Virus in Water Matrices: A Systematic Review and Meta-Analysis.International journal of environmental research and public health · 2023Pooled it
- Trends and risk factors associated with hepatitis A severity and mortality in French hospitals: a national population-based study, 2013 to 2024.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026Article
- Seroprevalence and risk factors of Hepatitis A virus among Palestinian refugees in North Lebanon: A pilot study to inform vaccination and public health policy.New microbes and new infections · 2026Article
- Estimating hepatitis A immunity and outbreak risk among MSM in New South Wales, Australia, 2017-2018.Epidemiology and infection · 2026Article
- Prevalence of Viral Hepatitis in Three Public Health Clinics in the Kingston Metropolitan Area, Jamaica, 2022.The American journal of tropical medicine and hygiene · 2026Article
- Single-Center Retrospective Study of Hospitalized Hepatitis A Cases in Southern Bulgaria, 2015-2023.Healthcare (Basel, Switzerland) · 2026Article
- Life-Threatening Gastrointestinal Bleeding in a Child with Acute Hepatitis A.Children (Basel, Switzerland) · 2026Article
- Assessing the global burden of acute viral hepatitis in the elderly: a comprehensive analysis of data from the GBD 2021 database.BMC infectious diseases · 2026Article
- Epidemiology of hepatitis A in Saudi Arabia: a retrospective analysis of Ministry of Health surveillance and yearbook data, 2006-2023.Frontiers in epidemiology · 2026Article
- Temporal trends in prevalence of chronic liver disease among women of childbearing age from 1992 to 2021.Frontiers in global women's health · 2026Article
- Trends in Incidence and Premature Mortality (Years of Life Lost) From Acute Viral Hepatitis Among Children Under Five in Ethiopia, From 1990 to 2023: A Global Burden of Disease 2023 Study.Global health, epidemiology and genomics · 2026Article
- Article
- Evolving trends in hepatitis A epidemiology: Shifting patterns, emerging risks, and future strategies.World journal of virology · 2025Review
- Hepatitis A: A wake-up call!Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2025Article
- Seroprevalence of Hepatitis A in Oman Prior to National Vaccination.Journal of clinical medicine · 2025Article
- Correlation of gallbladder wall pathology with controlled attenuation parameter, liver stiffness measurement, and laboratory markers in acute viral hepatitis A.Ultrasound (Leeds, England) · 2025Article
- Influence of substance use on rising hepatitis A hospitalizations in the United States: A decade-long comparative study.World journal of virology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
background and purposeDespite decades of improved sanitation and hygiene measures and vaccine introduction, hepatitis A has been spread through numerous outbreaks globally. We used data from the Global Burden of Disease (GBD) study to quantify hepatitis A burden at the global, regional and national levels.
methodsAnnual incident cases, deaths, age-standardized incidence rates (ASIRs), and age-standardized mortality rates (ASMRs) of hepatitis A between 1990 and 2019 were derived from the GBD study 2019. Percentage changes of cases and deaths, and estimated annual percentage changes (EAPCs) of ASIRs and ASMRs were calculated to quantify their temporal trends.
resultsGlobal hepatitis A incident cases increased by 13.90% from 139.54 million in 1990 to 158.94 million in 2019. ASIR of hepatitis A remained stable (EAPC = 0.00, 95% CI -0.01 to 0.01), whereas ASMR decreased (EAPC = -4.63, 95% CI -4.94 to -4.32) between 1990 and 2019. ASIR increased in low (EAPC = 0.09, 95% CI 0.04 to 0.14) and low-middle (EAPC = 0.04, 95% CI 0.03 to 0.06) socio-demographic index (SDI) regions. For GBD regions, the most significant increases of ASIR were detected in high-income Asia Pacific (EAPC = 0.53, 95% CI 0.41 to 0.66), Oceania (EAPC = 0.31, 95% CI 0.25 to 0.36), and Australasia (EAPC = 0.28, 95% CI 0.13 to 0.44). EAPC of ASIR was positively associated with SDI value in countries and territories with SDI value ≥ 0.7 (ρ = -0.310, p < 0.001).
conclusionThere is an unfavorable trend that hepatitis A is still pending in hyperendemic regions and is emerging in low endemic regions. These highlight the need of targeted and specific strategies to eliminate hepatitis A, such as sanitation measures and a comprehensive plan for surveillance and vaccination against hepatitis A.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.